Evidence map›Paper›PMID 40839057›Full record

ArticleInternational urology and nephrology2026

Beyond eGFR: critical appraisal of mannitol use in nephron- sparing surgery.

Huda Faisal, Siffat Ullah, Hussain Ramzan

Abstract readLetter
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Huda FaisalPeople's University of Medical and Health Sciences, Karachi, Pakistan.
Siffat UllahNishtar Medical College and Hospital, Multan, Pakistan.
Hussain RamzanNishtar Medical University and Hospital, Multan, Pakistan. hussainramzan101@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This letter evaluates the randomized trial by Cheriyan et al. regarding mannitol administration in laparoscopic nephron-sparing surgery. Major unaddressed limitations consist of arbitrary margin equivalences, dependence on per-protocol rather than intention-to-treat analysis, exclusion of functional renal imaging, and insufficient control of surgical confounders like warm ischemia duration. Moreover, the exclusion of individuals with chronic kidney disease limits generalizability. Drawing on previous PubMed-indexed studies, we emphasize these methodological flaws and promote the need for more stringent designs to elucidate mannitol's protective effects on the kidneys in contemporary nephron-sparing surgery.

Indexed as

Diuretics, OsmoticGlomerular Filtration RateMannitolNephrectomyNephronsOrgan Sparing TreatmentsHumansLaparoscopyRandomized Controlled Trials as TopicDiuretics, OsmoticMannitolchronic kidney diseasemetforminnephron

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.